VTP-100

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameVTP-100
Drug Alias NameInfluenza virus vaccine - VaccitechUniversal influenza vaccine - VaccitechMVA-NP+M1MVA-M1+NPVTP-100
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulantsInfluenza virus Matrix protein 1 inhibitors
TargetsInfluenza virus Matrix protein 1
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBarinthus Biotherapeutics PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBarinthus Biotherapeutics PLCUniversity Of Oxford
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A